Menu
← Oncology Approval Tracker
FDA DECISION ·
Pemfexy multidose vial
pemetrexed · Eagle Pharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Authorized multidose use of the 500 mg/20 mL Pemfexy vial for its already approved nonsquamous NSCLC and malignant pleural mesothelioma indications.
LAMPGEN ANALYSIS
Why it matters
Changed the approved vial presentation without changing which cancer populations could receive it.
What research teams should watch
Update multidose handling, storage and discard instructions in pharmacy procedures.
PRIMARY RECORDS